Breathe Well Live Well
|
Exhaled nitric oxide data affected treatment for patients with asthma
Healio “Asthma management in an outpatient setting is best accomplished by clinical evaluation coupled with spirometry and symptom evaluation, but these assessments do not provide information about airway inflammation,” researchers wrote. “Exhaled nitric … |
View full post on asthma – Google News
Headlines & Global News |
Asthma On The Decline In The US? New Data Could Be 'Statistical Blip'
Headlines & Global News About 7.4 percent of the U.S. population reported that they had asthma in 2013, compared with 8.5 percent in 2009, a U.S. Centers for Disease Control and Prevention (CDC) survey found, Reuters reported. Share This Story. This statistic would indicate a … |
View full post on asthma – Google News
|
MedImmune to present Phase IIb asthma data on benralizumab and …
News-Medical.net In the Phase IIb data being presented, both benralizumab and tralokinumab show promising safety and efficacy outcomes, suggesting they may offer important new therapeutic options for patients with specific forms of severe, uncontrolled asthma. |
View full post on asthma – Google News
|
Arthritis, lupus and asthma data a shot in arm for AstraZeneca
Reuters Benralizumab and tralokinumab both showed improvements in control of asthma in patients with specific, severe forms of the breathing disorder. All the drugs are being developed by MedImmune, the U.S.-based biotech company acquired by AstraZeneca in … |
View full post on asthma – Google News
Yahoo News |
UPDATE 1-Arthritis, lupus and asthma data a shot in arm for AstraZeneca
Reuters Benralizumab and tralokinumab both showed improvements in control of asthma in patients with specific, severe forms of the breathing disorder. All the drugs are being developed by MedImmune, the U.S.-based biotech company acquired by AstraZeneca in … Arthritis, lupus and asthma data a shot in arm for AstraZeneca AstraZeneca: Mavrilimumab Produces Rapid Improvement In Signs, Symptoms … AstraZeneca Says MedImmune Phase II Trials Data Positive |
View full post on asthma – Google News
Drug Discovery & Development |
Roche scores upbeat data for a personalized asthma drug with blockbuster hopes
FierceBiotech Roche's ($RHHBY) lebrikizumab significantly reduced the rate of asthma attacks in patients with a severe form of the disease, according to mid-stage trial results, lighting the way for a Phase III study on the novel, personalized treatment. The drug … Biologic May Tame Severe Asthma Roche drug cuts asthma attacks, improves lung function -study Lebrikizumab Phase 2b Data Show Reduction of Asthma Attack Rates |
View full post on asthma – Google News
|
Boehringer Ingelheim Presents Phase 3 Data for Tiotropium Across Asthma …
Drug Discovery & Development Boehringer Ingelheim announced new data from large scale, Phase 3 studies showing that once-daily tiotropium delivered via the Respimat inhaler was effective and well tolerated in patients across asthma severities. These data were presented at the … Tiotropium as Asthma Add-On Treatment Shows Promise |
View full post on asthma – Google News
|
Boehringer Ingelheim Presents Phase 3 Data for Tiotropium Across Asthma …
PR Newswire (press release) RIDGEFIELD, Conn., March 1, 2014 /PRNewswire/ — Boehringer Ingelheim today presented data from Phase 3 studies of tiotropium delivered via the Respimat® inhaler in mild, moderate and severe asthma patients at the 2014 American Academy of Allergy, … |
View full post on asthma – Google News
|
ASTHMA: New Phase III data show tiotropium * Respimat ® effective across …
Business Wire (press release) Boehringer Ingelheim today announced new data from large scale, Phase III studies showing that once-daily tiotropium delivered via the Respimat® inhaler was effective and well tolerated in patients across asthma severities. These data were presented at … |
View full post on asthma – Google News
Science Codex |
Maternal vitamin A deficiency linked to postnatal asthma: Mouse data
NutraIngredients.com The mouse study, published in the Journal of Clinical Investigation, provides evidence that a lack of vitamin A during pregnancy is linked to postnatal airway hyperresponsiveness, which is a hallmark of asthma. Led by Dr Wellington Cardoso from … Prenatal vitamin A deficiency tied to postnatal asthma First evidence of link between prenatal vitamin A deficiency and postnatal asthma |
View full post on asthma – Google News